Steven A. Moore, MD, PhD

Portrait
Co-Director, Wellstone Muscular Dystrophy Cooperative Research Center
Director of Neuropathology
Professor of Pathology

Contact Information

Primary Office: 5239B Roy Carver Pavilion
Iowa City, IA 52242
319-384-9084

Lab: 4270A Carver Biomedical Research Building
Iowa City, IA 52242
319-335-8215

Education

BS, Purdue University
PhD, Anatomy, Indiana University
MD, Indiana University School of Medicine

Resident, Pathology, University of Iowa College of Medicine
Fellow, Neuropathology, University of Iowa College of Medicine

Licensure and Certifications

Anatomic Pathology - American Board of Pathology
Neuropathology - American Board of Pathology

Education/Training Program Affiliations

Department of Pathology Graduate Program, Interdisciplinary Graduate Program in Neuroscience

Center, Program and Institute Affiliations

Center for Gene Therapy of Cystic Fibrosis and other Genetic Diseases, Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center

Research Summary

Muscular dystrophies are a diverse group of inherited disorders characterized by progressive muscle weakness and wasting. Dr. Moore is involved in the evaluation of patient biopsies and in research partially funded through a center grant from NIH. This Paul D. Wellstone Muscular Dystrophy Cooperative Research Center is exploring therapeutic strategies for the treatment of various muscular dystrophies by enabling translational research on muscular dystrophies and providing advanced diagnostic services. The MDCRC is composed of two research projects, three cores and investigators with a proven track record of excellence and collaboration. The Center researchers' studies and facilities will explore basic biological mechanisms that relate to possible treatments for muscular dystrophies, facilitate translational research on muscular dystrophies and provide advanced diagnostic services to patients and clinical trial participants. The Director and Co-director, Kevin Campbell and Steven Moore, are investigators with established records in basic, translational, and clinical research on muscular dystrophy.

Additional basic science collaboration with Dr. Kevin Campbell, Department of Molecular Physiology and Biophysics ( The Laboratory of Dr. Kevin P. Campbell) involves the pathologic characterization of genetic mouse models of muscular dystrophy. Many of these models use Cre-lox methodology to selectively knock out brain or peripheral nerve dystroglycan. These mice model congenital muscular dystrophy. A second basic science collaboration is with Lori Wallrath (Department of Biochemistry, The University of Iowa) studying lamin A/C.

Including the Wellstone MDCRC mentioned above, clinical diagnostic work in the general area of muscular dystophies has expanded into basic and clinical research projects in collaboration with several physicians at other institutions, Kevin Campbell, and Kathy Mathews (Department of Pediatrics, The University of Iowa). Current clinical studies involve: (1) a natural history study of patients with dystroglycanopathy, (2) a search for new genes in congenital myopathy and muscular dystrophy patients, (3) dysferlinopathy patients with amyloid deposition, (4) autophagic vacuolar myopathy patients, and (5) improvements in diagnostic testing.

Publications

Wilson, K., Faelan, C., Patterson-Kane, J. C., Rudmann, D. G., Moore, S. A., Frank, D., Charleston, J., Tinsley, J., Young, G. D. & Milici, A. J. (2017). Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification. Toxicologic pathology, 45(7), 961-976. PMID: 28974147.

Shaw, N. D., Brand, H., Kupchinsky, Z. A., Bengani, H., Plummer, L., Jones, T. I., Erdin, S., Williamson, K. A., Rainger, J., Stortchevoi, A., Samocha, K., Currall, B. B., Dunican, D. S., Collins, R. L., Willer, J. R., Lek, A., Lek, M., Nassan, M., Pereira, S., Kammin, T., Lucente, D., Silva, A., Seabra, C. M., Chiang, C., An, Y., Ansari, M., Rainger, J. K., Joss, S., Smith, J. C., Lippincott, M. F., Singh, S. S., Patel, N., Jing, J. W., Law, J. R., Ferraro, N., Verloes, A., Rauch, A., Steindl, K., Zweier, M., Scheer, I., Sato, D., Okamoto, N., Jacobsen, C., Tryggestad, J., Chernausek, S., Schimmenti, L. A., Brasseur, B., Cesaretti, C., García-Ortiz, J. E., Buitrago, T. P., Silva, O. P., Hoffman, J. D., Mühlbauer, W., Ruprecht, K. W., Loeys, B. L., Shino, M., Kaindl, A. M., Cho, C. H., Morton, C. C., Meehan, R. R., van Heyningen, V., Liao, E. C., Balasubramanian, R., Hall, J. E., Seminara, S. B., Macarthur, D., Moore, S. A., Yoshiura, K. I., Gusella, J. F., Marsh, J. A., Graham, Jr, J. M., Lin, A. E., Katsanis, N., Jones, P. L., Crowley, Jr, W. F., Davis, E. E., FitzPatrick, D. R. & Talkowski, M. E. (2017). SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome. Nature genetics, 49(2), 238-248. PMID: 28067909.

Donkervoort, S., Chan SHS,, Hayes, L. H., Bradley, N., Nguyen, D., Leach, M. E., Mohassel, P., Hu, Y., Thangarajh, M., Bharucha-Goebel, D., Kan, A., Ho RSL,, Reyes, C. A., Nance, J., Moore, S. A., Foley, A. R. & Bönnemann, C. G. (2017). Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rods. Neuromuscular disorders : NMD. PMID: 28416349.

Wilson, K., Faelan, C., Patterson-Kane, J. C., Rudmann, D. G., Moore, S. A., Frank, D., Charleston, J., Tinsley, J., Young, G. D. & Milici, A. J. (2017). Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification. Toxicologic pathology, 45(7), 961-976. PMID: 28974147.

Quinn, C., Moore, S. A., Bardakjian, T. M. & Karam, C. (2016). Clinical Reasoning: A 30-year-old man with progressive weakness and atrophy. Neurology, 87(19), e227-e230. PMID: 27821570.

Clancy, C. D., Forde, B. M., Moore, S. A. & O'Toole, P. W. (2016). Correction for Clancy et al., Draft Genome Sequences of Helicobacter pylori Strains 17874 and P79. Journal of bacteriology, 198(13), 1902. PMID: 27298283.

Lawlor, M. W., Beggs, A. H., Buj-Bello, A., Childers, M. K., Dowling, J. J., James, E. S., Meng, H., Moore, S. A., Prasad, S., Schoser, B. & Sewry, C. A. (2016). Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons. pp. 102-110. J Neuropathol Exp Neurol. PMID: 26823526.

Strickland, A. V., Schabbutl, M., Offenbacher, H., Synofzik, M., Hauser, N. A., Brunner-Krainz, M., Gruber-Sedlmayr, U. & Moore, S. (2015). Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1. J Neurol.. PMID: 26100331.

Dialynas, G., Shrestha, O. K., Ponce, J. M., Zwerger, M., Thiemann, D. A., Young, G. H., Moore, S. a., Yu, L., Lammerding, J. & Wallrath, L. L. (2015). Myopathic Lamin Mutations Cause Reductive Stress and Activate the Nrf2/Keap-1 Pathway. PloS Genet, 11(5). PMID: 25996830.

Brennan, K. M., Bai, Y., Pisciotta, C., Wang, S., Feely, S. M., Hoegger, M., Gutman, L., Moore, S. A., Gonzalez, M., Sherman, D. L., Brophy, P. J., Zuchner, S. & Shy, M. E. (2015). Absence of Dystrophin Related Protein-2 disrupts Cajal bands in a patient with Charcot-Marie-Tooth disease. Neuromuscul Disord, 15, 659-8. PMID: 26227883.

Pisciotta, C., Bai, Y., Brennan, K. M., Wu, X., Grider, T., Feely, S., Wang, S., Moore, S., Siskind, C., Gonzales, M., Zuchner, S. & Shy, M. E. (2015). Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E. Neurology. PMID: 26109717.

Jensen, B. S., Willer, T., Saade, D. N., Cox, M. O., Mozaffar, T., Scavina, M., Steffans, V. A., Winder, T. L., Campbell, K. P., Moore, S. A. & Mathews, K. D. (2015). Gmppb-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation. Hum Mutat. PMID: 26310427.

Tsuda, T., Fitzgerald, K., Scavena, m., Gidding, S., Cox, M. O., Marks, H., Flanigan, K. M. & Moore, S. A. (2015). Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27. (Vols. 60). pp. 151-155. J Hum Genet. PMID: 25537791.

Dowling, J. J., Moore, S. A., Kalimo, H. & Minassian, B. (2015). X-linked autophagic vacuolar myopathy: a failure of self eating. Acta Neuropathol, 129, 383-390. PMID: 25644398.

Crockett, C. D., Bertrand, L. A., Cooper, C. S., Rahhal, R. M., Liu, K., Zimmerman, M. B., Moore, S. A. & Mathews, K. D. (2015). Urologic and gastrointestinal symptoms in the dystroglycanopathies. Neurology. PMID: 25568299.

Jerath, N. U., Crockett, C. D., Moore, S. A., Shy, M. E., Weihl, C. C., Chou, T. F., Grider, T., Gonzalez, M. A., Zuckner, S. & Swenson, A. (2015). Rare manifestation of a c.290C>T, p.Gly97Glu VCP mutation. Case Reports Genet, 2015. PMID: 25878907.

Bharucha-Goebel, D. X., Neil, E., Donkervoort, S., Dastgir, J., Wiggs, E. A., Winder, T. L., Moore, S. A., Iannaccone, S. & Bonnemann, C. G. (2015). Intrafamilial variability in GMPPB associated dystroglycanopathy: broadening the clinical phenotype. Neurology. PMID: 25770200.

Sanmaneechai, O., Swenson, A., Gerke, A. K., Moore, S. A. & Shy, M. E. (2015). Inclusion body myositis with sarcoidosis: A case report. Neuromuscul Disord, 25, 297-300. PMID: 25599912.

Al-Zaidy, S. A., Malik, V., Kneile, K., Rosales, X. Q., Gomez, A. M., Lewis, S., Gastier-Foster, J., Kang, P., Darras, B., Kunkel, L., Carlo, J., SAhenk, Z., Moore, S. A., Pyatt, R. & Mendell, J. R. (2015). Slowly progressive limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics. Mol Genet Genomic Med, 3, 92-98. PMID: 25802879.

Crockett, C. D., Ruggieri, A., Gujrati, M., Zallek, C. M., Ramachandran, N., Minassian, B. A. & Moore, S. A. (2014). Late-adult onset of X-liked myopathy with excessive autophagy (XMEA). Muscle Nerve, 50, 138-144.

Chauveau, C., Bonnemann, C. G., Julien, C., Ay Lin Kho, A. L., Marks, H., Talim, B., Maury, P., Arne-Bes, M. C., Uro-Coste, E., Alexandrovich, A., Vihola, A., Schäfer, S., Kaufmann, B., Medne, L., Hübner, N., Foley, A. R., Santi, M., Udd, B., Topaloglu, H., Moore, S. A., Gotthardt, M., Samuels, M. E., Gautel, M. & Ferreiro, A. (2014). Homozygous or compound heterozygous truncating mutations of TTN define novel forms of heart disease with congenital myopathy. Hum Mol Genet, 23, 980-991. PMID: 24105469.

Wallace, S. E., Conta, J. H., Winder, T. L., Willer, T., Eskuri, J. M., Haas, R., Patterson, K., Campbell, K. P., Moore, S. A. & Gospe, S. M. (2014). A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated wtih POMT1 nonsense mutations. Neuromuscul Disord, 24, 312-320. PMID: 24491487.

Bushby, K., Finkel, R., Wong, B., Barohn, R., Campbell, C., Comi, G. P., Connolly, A. M., Day, J. W., Flanigan, K. M., Goemans, N., Jones, K. J., Mercuri, E., Quinlivan, R., Renfroe, J. B., Russman, B., Ryan, M. M., Tulinius, M., Voit, T., Moore, S. A., Lee Sweeney, H., Abresch, R. T., Coleman, K. L., Eagle, M., Florence, J., Gappmaier, E., Glanzman, A. M., Henricson, E., Barth, J., Elfring, G. L., Reha, A., Spiegel, R. J., O'Donnell, M. W., Peltz, S. W. & McDonald, C. M. (2014). Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve, 50(4), 477-87. PMID: 25042182.

Bonnemann, C. G., Wang, C. H., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Beroud, C., Mathews, K. D., Moore, S. A., Bellini, J., Rutkowski, A. & North, K. N. (2014). Diagnostic approach to the congenital muscular dystrophies: consensus on the state of the art. Neuromuscul Disord, 24(4), 289-311.

Moore, S. A., Bossler, A., Brownstein, C. A., Beggs, A. H., Homer, N., Mathews, K. & Margulies, D. M. (2014). An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY challenge. Genome Biol, 15(3), R53. PMID: 24667040.

Inamori, K. I., Willer, T., Hara, Y., Venzke, D., Anderson, M. E., Clarke, N. F., Guicheney, P., Bönnemann, C. G., Moore, S. A. & Campbell, K. P. (2014). Endogenous glucuoronyltransferase activity of LARGE and LARGE2 required for functional modification of a-dystroglycan in cells and tissues. (Vols. 289). (41), pp. 138-48. J Biol Chem. PMID: 25138275.

Goddeeris, M. M., Wu, B., Venzke, D., Yoshida-Moriguchi, T., Saito, F., Matsumura, K., Moore, S. A. & Campbell, K. P. (2013). LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature, 503(7474), 136-40. PMID: 24132234.

McDonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J. M., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124-GD-007-DMD Study Group, Spiegel, R., Barth, J., Elfring, G., Reha, A. & Peltz, S. (2013). The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve, 48, 343-56. PMID: 23681930.

Lin, L. H., Moore, S. A., Jones, S. Y., McGlashon, J. & Talman, W. T. (2013). Astrocytes in the nucleus tractus solitarii are critical for cardiovascualr reflex control. J Neurosci, 33, 18608-18617. PMID: 24259582.

Moore, S. A., Gujrati, M., Zallek, C. M., Ramachandran, N. & Minassian, B. (2013). Late-adult onset of X-linked myopathy with excess autophagy (XMEA). (Vols. 72). pp. 586. J Neuropathol Exp Neurol.

Carss, K. J., Stevens, E., Foley, A. R., Cirak, S., Riemersma, M., Torelli, S., Hoischen, A., Willer, T., van Scherpenzeel, M., Moore, S. A., Messina, S., Bertini, E., Bonnemann, C. G., Abdenur, J. E., Grosmann, C. M., Kesari, A., Punetha, J., Quinlivan, R., Waddell, L. B., Young, H. K., Wraige, E., Yau, S., Brodd, L., Feng, L., Sewry, C., MacArthur, D. G., North, K. B., Hoffman, E., Stemple, D., Hurles, M., van Bokhoven, H., Campbell, K. P., Lefeber, D. J., Lin, Y. Y. & Muntoni, F. (2013). Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb girdle muscular dystrophies associated with hypoglycosylation of a-dystroglycan. Am J Hum Genet, 93, 1-13. PMID: 23768512.

Nguyen, H., Ostendorf, A. P., Satz, J. S., Westra, S., Ross-Barta, S. E., Campbell, K. P. & Moore, S. A. (2013). Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins. Acta Neuropathol Comms, 1, 58. PMID: 24252195.

Cirak, S., Foley, A. R., Herrmann, R., Willer, T., Yau, S., Stevens, E., Torelli, S., Brodd, L., Kamynina, A., Vondracek, P., Roper, H., Longman, C., Korinthenberg, R., Marrosu, G., Nurnberg, P., Michele, D. E., Plagnol, V., Hurles, M., Moore, S. A., Sewry, C. A., Campbell, K. P., Voit, T. & Muntoni, F. (2013). ISPD Gene Mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain, 136(Pt 1), 269-81. PMID: 23288328.

Khoo, M. K., Hebbar, S. A., Zhao, W., Moore, S. A., Oberley, L. W., Domann, F. E. & Robbins, M. E. (2013). Differential Activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy. Redox Biology, 1(1), 70-79. PMID: 24024139.

Davidson, A. E., Siddiqui, F. M., Lopez, M., Lunt, P., Carlson, H. A., Moore, B. E., Love, S., Roper, H., Born, D. E., Majumdar, A., Jayadev, S., Underhill, H. R., Smith, C. O., von der Hagen, J., Hubner, A., Jardine, P., Merrison, A., Curtis, E., Cullup, T., Jungbluth, H., Cox, M. O., Winder, T. L., Abdel-Salam, H., Li, J. Z., Moore, S. A. & Dowling, J. J. (2013). Novel deletion of lysine 7 expands the clinical, histopathologic and genetic spectrum of TPM2-related myopathies. Brain, 136, 508-521. PMID: 23413262.

Eskuri, J. M., Stanley, C. M., Moore, S. A. & Mathews, K. (2012). Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS. J Peripheral Nervous System, 17(1), 132-4. PMID: 22462675.

McGaughey, S. D., Nelson, T., Cox, M. O. & Moore, S. A. (2012). Evaluation of calpain-3 in patients with limb-girdle muscular dystrophy. (Vols. 71). pp. 574. J Neuropathol Exp Neurol.

Dialynas, G., Flannery, K. M., Zirbel, L. N., Nagy, P. L., Mathews, K., Moore, S. A. & Wallrath, L. (2012). LMNA variants cause cytoplasmic distribution of nuclear pore proteins in Drosophila and human muscle. Human Molecular Genetics, 21(7), 1544-56. PMID: 22186027.

Dowling, J. J., Davidson, A. E., Lopez, M., Siddiqui, F. M., Lung, P., Li, J. Z., Jungbluth, H., Love, S. & Moore, S. A. (2012). Expanding the clinical and genetic phenotype of TPM2-related myopathies. (Vols. 22). pp. 821. Neuromusc Disorders.

Martin, S. E., Moore, S. A., bodkin, C. & Hattab, E. M. (2012). Myofibrillar myopathy with large cores: A case report. (Vols. 71). pp. 587. J Neuropathol Exp Neurol.

Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., Beltran Valero de Bernabe, D. B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Strahl, S., Mathews, K., Nelson, S. F., Moore, S. A. & Campbell, K. P. (2012). Patient fibroblast functional complementation studies: a valuable tool in the identification of novel Walker-Warburg syndrome disease genes. (Vols. 22). pp. 805. Neuromusc Disorders.

Tesi Rocha, C., Taylor, M., Chang, T., Reyes, C., Winder, T., Moore, S. A., Bonnemann, C. & Nelson, K. (2012). Novel homozygous stop mutation in alphaB crystalline: expanding the phenotype. (Vols. 22). pp. 821. Neuromusc Disorders.

Moore, S. A., Winder, T. L., Nelson, T., Cox, M. O., Reyes, C., Tesi-Rocha, C. & Chang, T. (2012). Novel homozygous stop mutation in alphaB crystallin (CRYAB:p.Ser135*) causes fatal congenital form of myofibillar myopathy. (Vols. 71). pp. 587-588. J Neuropathol Exp Neurol.

Moore, S. A., Moore, B. E., Love, S., Li, J. Z., Lopez, M., von der Hagen, M., Hubner, A., Winder, T. L., Cullup, T., Majumdar, A., Abdel-Salam, H., Siddiqui, F. M., Lung, P. & Dowling, J. J. (2012). Novel beta-tropomyosin mutation (TPM2) causes distal core-rod myopathy and trismus-pseudocamptodactyly with nemaline rods. (Vols. 71). pp. 575. J Neuropathol Exp Neurol.

Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., de Bernabe, D. B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Loder, A. S., Dobyns, W. B., Winder, T. L., Strahl, S., Mathews, K., Nelson, S. F., Moore, S. A. & Campbell, K. P. (2012). ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nature Genetics, 44(5), 575-80. PMID: 22522420.

Chauveau, C., Julien, C., Marks, H., Foley, R., Kho, A. L., Talim, B., Arne-Bes, M. C., Uro-Coste, E., Maury, P., Vihola, A., Udd, B., Topaloglu, H., Moore, S. A., Gautel, M., Bonnemann, C., Samuels, M. E. & Ferreiro, A. (2012). Tackling giants with next generation sequencing: Homozygous or compound heterozygous truncating mutations of TTN define novel forms of cardiomyopathy with skeletal myopathy. American Society of Medical Genetics.

Joiner, M. A., Koval, O. M., Li, J., He, B. J., Allamargot, C., Guo, Z., Luczak, E. D., Hall, D., Fink, B. D., Chen, B., Yang, J., Moore, S. A., Scholz, T., Strack, S., MOHLER, P. J., Sivitz, W. I., Song, L. & Anderson, M. E. (2012). CaMKII determines mitochondrial stress responses in heart. Nature, 491, 269-273. PMID: 23051746.

Talman, W., Dragon, D. N., Jones, S. Y., Moore, S. A. & Lin, L. H. (2012). Sudden death and myocardial lesions after damage to catecholamine neurons of the nucleus tractus solitarii in rat. Cellular Mol Neurobiol, 32(7), 1119-26. PMID: 22484855.

Acsadi, G., Moore, S. A., Chéron, A., Delalande, O., Bennett, L., Kupsky, W., El-Baba, M., Le Rumeur, E. & Hubert, J. F. (2012). A novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy. J Biol Chem, 287(22), 18153-62. PMID: 22453924.

Myshrall, T. M., Moore, S. A., Ostendorf, A. P., Satz, J. S., Kowalczyk, T., Nguyen, H. T., Daza, R. A., Lau, C., Campbell, K. P. & Hevner, R. F. (2012). Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex. J Neuropathol Exp Neurol, 71, 1047-1063. PMID: 23147502.

Dowling, J. J., Davidson, A. E., Lopez, M., Siddiqui, F. M., Lung, P., Li, J. Z., Jungbluth, H., Love, S. & Moore, S. A. (2012). Expanding the clinical and genetic phenotype of TPM2-related myopathies. World Muscle Society.

Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., Beltran Valero de Bernabe, D. B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Strahl, S., Mathews, K., Nelson, S. F., Moore, S. A. & Campbell, K. P. (2012). Patient fibroblast functional complementation studies: a valuable tool in the identification of novel Walker-Warburg syndrome disease genes. World Muscle Society.

Tesi Rocha, C., Taylor, M., Chang, T., Reyes, C., Winder, T., Moore, S. A., Bonnemann, C. & Nelson, K. (2012). Novel homozygous stop mutation in alphaB crystalline: expanding the phenotype. World Muscle Society.

Nguyen, N., Satz, J. S., Turk, R., Campbell, K. P. & Moore, S. A. (2012). Neuronal alpha-dystroglycan is important for proper GABAA receptor-alpha1 clustering in Purkinje neurons. Society for Neuroscience Meeting.

Mathews, K., Stephan, C. M., Laubenthal, K., Winder, T. L., Michele, D. E., Moore, S. A. & Campbell, K. P. (2011). Myoglobinuria and muscle pain are common in patients with limb-girdle muscular dystrophy 2I. Neurology, 76(2), 194-5. PMID: 21220724.

Kazmi, S. A., McComb, R. D., Gokden, M., Spuler, S., Filho, J. A., Huston, K. A., Gundogdu, B. & Moore, S. A. (2011). Amyloid myopathy associated with dysferlinopathy: comparison with light chain amyloidosis. (Vols. 70). pp. 524. J Neuropathol Exp Neurol.

Gundogdu, B. M., Rudnicki, S., Al-Lahham, T., Gokden, M. & Moore, S. A. (2011). A young patient with amyloid deposits in the muscle. Carrell-Krusen Neuromuscular Symposium, Dallas, TX.

Di Blasi, C., Bellafiore, E., Salih, M. A., Manzini, M. C., Moore, S. A., Seidahmed, M. Z., Mukhtar, M. M., Karrar, Z. A., Walsh, C. A., Campbell, K. P., Mantegazza, R., Morandi, L. & Mora, M. (2011). Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. BMC Research Notes, 4(1), 534. PMID: 22166137.

Mathews, K., Nagan, M. R., Moore, S. A. & Stephan, S. M. (2010). Progressive childhood-onset hearing loss in FSHD. Child Neurology Society annual meeting.

Trantow, C. M., Hedberg-Buenz, A., Iwashita, S., Moore, S. A. & Anderson, M. G. (2010). Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes. PLoS genetics, 6(7), e1001008. PMID: 20617205.

Satz, J. S., Ostendorf, A. P., Hou, S., Turner, A., Kusano, H., Lee, J. C., Turk, R., Nguyen, H., Ross-Barta, S. E., Westra, S., Hoshi, T., Moore, S. A. & Campbell, K. P. (2010). Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. J Neurosci, 30(43), 14560-72. PMID: 20980614.

Guo, L. T., Moore, S. A., Forcales, S., Engvall, E. & Shelton, G. D. (2010). Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle. Neuromuscular Disorders, 20(12), 820-5. PMID: 20817457.

Han, R., Frett, E. M., Levy, J. R., Rader, E. P., Lueck, J. D., Bansal, D., Moore, S. A., Ng, R., Beltrán-Valero de Bernabé, D., Faulkner, J. A. & Campbell, K. P. (2010). Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest, 120(12), 4366-74. PMID: 21060153.

Nayate, A., Moore, S. A., Weiss, R. M., Taktakishvili, O. M., Lin, L. H. & Talman, W. (2009). Cardiac damage after lesions of the nucleus tractus solitarii. Am J Physiol Regul Integr Comp Physiol, 296(2), R272-9. PMID: 19020288.

Wakefield, S. E., Dimberg, E. L., Moore, S. A. & Tseng, B. S. (2009). Dystrophinopathy presenting with arrhythmia in an asymptomatic 34-year-old man: a case report. J Med Case Reports, 3, 8625. PMID: 19830234.

Nguyen, H., Ostendorf, A., Satz, J., Campbell, K. P. & Moore, S. A. (2009). Dystroglycan and cerebellar granule neuron development. (Vols. 68). pp. 554-555. J Neuropathol Exp Neurol.

Cox, E. M., Darbro, B., Mathews, K., Nagy, P. L., CABUAY, B. M. & Moore, S. A. (2009). Novel LMNA mutation in a North American family with LGMD1B and dilated cardiomyopathy. (Vols. 68). pp. 555. J Neuropathol Exp Neurol.

Han, R., Kanagawa, M., Yoshida-Moriguchi, T., Rader, E. P., Ng, R. A., Michele, D. E., Muirhead, D. E., Kunz, S., Moore, S. A., Iannaccone, S. T., Miyake, K., McNeil, P. L., Mayer, U., Oldstone, M. B., Faulkner, J. A. & Campbell, K. P. (2009). Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci USA, 106(31), 12573-9. PMID: 19633189.

Satz, J. S., Philp, A. R., Nguyen, H. M., Kusano, H., Lee, J., Turk, R., Riker, M. J., Hernández, J., Weiss, R. M., Anderson, M. G., Mullins, R. F., Moore, S. A., Stone, E. M. & Campbell, K. P. (2009). Visual impairment in the absence of dystroglycan. J Neurosci, 29(42), 13136-46. PMID: 19846701.

Puckett, R. L., Moore, S. A., Winder, T. L., Willer, T., Romansky, S. G., Covault, K. K., Campbell, K. P. & Abdenur, J. E. (2009). Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. Neuromusc Dis, 19(5), 352-6. PMID: 19342235.

Margeta, M., Connolly, A. M., Winder, T. L., Pestronk, A. & Moore, S. A. (2009). Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I. Muscle & Nerve, 40(5), 883-9. PMID: 19705481.

Rodríguez-Lebrón, E., Gouvion, C. M., Moore, S. A., Davidson, B. L. & Paulson, H. L. (2009). Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease. Mol Ther, 17(9), 1563-73. PMID: 19532137.

Chang, W., Winder, T. L., LeDuc, C. A., Simpson, L. L., Millar, W. S., Dungan, J., Ginsberg, N., Plaga, S., Moore, S. A. & Chung, W. K. (2009). Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn, 29(6), 560-9. PMID: 19266496.

Moore, S. A., Lamande, S. R. & Winder, T. L. (2008). Diagnostic Testing for Congenital Muscular Dystrophies in a Cohort of USA Patients. Biology and Disease of Skeletal Muscle Meeting.

Ferraris, S., Clark, S., Garelli, E., Davidzon, G., Moore, S. A., Kardon, R. H., Bienstock, R. J., Longley, M. J., Mancuso, M., Gutiérrez Ríos, P., Hirano, M., Copeland, W. C. & DiMauro, S. (2008). Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Arch Neurol, 65(1), 125-31. PMID: 18195150.

Spuler, S., Carl, M., Zabojszcza, J., Straub, V., Bushby, K., Moore, S. A., Bähring, S., Wenzel, K., Vinkemeier, U. & Rocken, C. (2008). Dysferlin-deficient muscular dystrophy features amyloidosis. Ann Neurol, 63(3), 323-8. PMID: 18306167.

Kobuke, K., Piccolo, F., Garringer, K. W., Moore, S. A., Sweezer, E., Yang, B. & Campbell, K. P. (2008). A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice. Hum Mol Genet, 17(9), 1201-13. PMID: 18252746.

Kobayashi, Y. M., Rader, E. P., Crawford, R. W., Iyengar, N. K., Thedens, D. R., Faulkner, J. A., Parikh, S. V., Weiss, R. M., Chamberlain, J. S., Moore, S. A. & Campbell, K. P. (2008). Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature, 456(7221), 511-5. PMID: 18953332.

Netland, J., Meyerholz, D., Moore, S. A., Cassell, M. & Perlman, S. (2008). Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virology, 82(15), 7264-75. PMID: 18495771.

Mathews, K., Stephan, C. M., Laubenthal, K. S. & Moore, S. A. (2008). Genotype and phenotype analysis of a North American cohort with FKRP mutations: congenital muscular dystrophy 1C (MDC 1C) and limb girdle muscular dystrophy 2I (LGMD 2I). Child Neurology Society Meeting.

Satz, J. S., Barresi, R., Durbeej, M., Willer, T., Turner, A., Moore, S. A. & Campbell, K. P. (2008). Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. J Neurosci, 28(42), 10567-75. PMID: 18923033.

Pace, R. A., Peat, R. A., Baker, N. L., Zamurs, L., Mörgelin, M., Irving, M., Adams, N. E., Bateman, J. F., Mowat, D., Smith, N. J., Lamont, P. J., Moore, S. A., Mathews, K., North, K. N. & Lamandé, S. R. (2008). Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity. Ann Neurol, 64(3), 294-303. PMID: 18825676.

McComb, R. D., Radio, S. J., McAllister, J. L., Erickson, C. C., Pattee, G. L. & Moore, S. A. (2007). Danon disease (autophagocytic vacuolar myopathy): clinicopathologic features of a kindred. (Vols. 21). pp. A399. FASEB J.

Yokoyama, T., Lisi, T. L., Moore, S. A. & Sluka, K. A. (2007). Muscle fatigue increases the probability of developing hyperalgesia in mice. J Pain, 8(9), 692-9. PMID: 17627895.

Winder, T. L., Laffin, J. S. & Moore, S. A. (2007). Common mutations detected for diagnosis of limb-girdle muscular dystrophy. (Vols. 21). pp. A398-399. FASEB J.

Moore, S. A., Shilling, C. J., Westra, S., Wall, C., Wicklund, M. P., Stolle, C., Brown, C. A., Michele, D. E., Piccolo, F., Winder, T. L., Stence, A., Barresi, R., King, N., King, W., Florence, J., Campbell, K. P., Fenichel, G. M., Stedman, H. H., Kissel, J. T., Griggs, R. C., Pandya, S., Mathews, K., Pestronk, A., Serrano, C., Darvish, D. & Mendell, J. R. (2006). Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol, 65(10), 995-1003. PMID: 17021404.

Khalsa, S. S., Moore, S. A. & Van Hoesen, G. W. (2006). Hughlings Jackson and the role of the entorhinal cortex in temporal lobe epilepsy: from patient A to Doctor Z. Epilepsy & Behavior, 9(3), 524-31. PMID: 16942917.

Fang, X., Faraci, F. M., Kaduce, T. L., Harmon, S., Modrick, M. L., Hu, S., Moore, S. A., Falck, J. R., Weintraub, N. L. & Spector, A. A. (2006). 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. Am J Physiol Heart Circ Physiol, 291(5), H2301-7. PMID: 16782846.

Ostendorf, A., Satz, J., Westra, S., Ross-Barta, S. E., Campbell, K. P. & Moore, S. A. (2005). Abnormal cerebral histogenesis following deletion of dystroglycan. (Vols. 64). (64), pp. 446. J Neuropathol Exp Neurol.

Chen, P., Hu, S., Yao, J., Moore, S. A., Spector, A. A. & Fang, X. (2005). Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvascular Res, 69(2-Jan), 28-35. PMID: 15797258.

Apostolova, L. G., White, M., Moore, S. A. & Davis, P. (2005). Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol, 62(7), 1154-6. PMID: 16009776.

Occhi, S., Zambroni, D., Del Carro, U., Amadio, S., Sirkowski, E. E., Scherer, S. S., Campbell, K. P., Moore, S. A., Chen, Z. L., Strickland, S., Di Muzio, A., Uncini, A., Wrabetz, L. & Feltri, M. L. (2005). Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci, 25(41), 9418-27. PMID: 16221851.

Collins, X. H., Harmon, S. D., Kaduce, T. L., Berst, K. B., Fang, X., Moore, S. A., Raju, T. V., Falck, J. R., Weintraub, N. L., Duester, G., Plapp, B. V. & Spector, A. A. (2005). Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. J Biol Chem, 280(39), 33157-64. PMID: 16081420.

Moore, S. A., Shilling, C. J., Westra, S., Wicklund, M. P., Brown, C. A., Michele, D. A., Stolle, C. A., Campbell, K. P., Fenichel, G. M., Griggs, R. C., Kissel, J. T., Mathews, K., Pestronk, A., Wal, C. & Mendell, J. R. (2004). Limb-Girdle Muscular Dystrophy in the USA: distribution of immunophenotypes and genotypes from an ongoing multi-center collaborative study. (Vols. 63). pp. 532. J Neuropathol Exp Neurol.

Mathews, K., Moore, S. A. (2004). Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?. Arch Neurol, 61(1), 27-9. PMID: 14732615.

Moore, S. A., Ross-Barta, S. E., Westra, S., Saito, F., Messing, A., Bajenaru, M. L., Gutmann, D. & Campbell, K. P. (2004). Cerebellar dysgenesis correlates with the timing and extent of dystroglycan deletion in conditional knockout mice. (Vols. 63). pp. 519. J Neuropathol Exp Neurol.

Barresi, R., Michele, D. E., Kanagawa, M., Harper, H. A., Dovico, S. A., Satz, J. S., Moore, S. A., Zhang, W., Schachter, H., Dumanski, J. P., Cohn, R. D., Nishino, I. & Campbell, K. P. (2004). LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nature Medicine, 10(7), 696-703. PMID: 15184894.

Chen, P., Hu, S., Harmon, S. D., Moore, S. A., Spector, A. A. & Fang, X. (2004). Metabolism of anandamide in cerebral microvascular endothelial cells. Prostaglandins Other Lipid Mediat, 73(2-Jan), 59-72. PMID: 15165032.

Mathews, K., Moore, S. A. (2003). Limb Girdle Muscular Dystrophy. (Vols. 3). pp. 78-85. Current Neurology and Neuroscience Reports. PMID: 12507416.

Saito, F., Moore, S. A., Barresi, R., Henry, M. D., Messing, A., Ross-Barta, S. E., Cohn, R. D., Williamson, R. A., Sluka, K. A., Sherman, D. L., Brophy, P., Schmelzer, J. D., Low, P. A., Wrabetz, L., Feltri, M. L. & Campbell, K. P. (2003). Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron, 38(5), 747-58. PMID: 12797959.

Radhakrishnan, R., Moore, S. A. & Sluka, K. A. (2003). Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain, 104(3), 567-77. PMID: 12927629.

Bailey, M. C., Dickerson, L. W., Moore, S. A., Schutte, B. C. & Lamb, F. S. (2002). CFTR/CIC-3 double knockout mice display dramatically increased mortality. FASEB J.

Moore, S. A., Saito, F., Henry, M. D., Messing, A., Low, P. A., Wrabetz, L., Feltri, L. & Campbell, K. P. (2002). Peripheral neuropathy with folded myelin sheaths in mice lacking Schwann cell dystroglycan. (Vols. 61). pp. 485. J Neuropathol Exp Neurol.

Bilunas, M. H., Moore, S. A. (2002). Cyclooxygenase-2 expression and activity are induced by amyloid-beta 1-42 in brain-derived cells. In K. V. Honn (Eds.) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, vol 5. pp. 93-99. Plenum Publishing Corp., New York, NY, Adv Exp Med Biol.

Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., Straub, V., Mathews, K., Moore, S. A. & Campbell, K. P. (2002). Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature, 418(6896), 417-22. PMID: 12140558.

Cohn, R. D., Henry, M., Michele, D. E., Barresi, R., Saito, F., Moore, S. A., Flanagan, J. D., Skwarchuk, M. W., Robbins, M. E., Mendell, J. R., Williamson, R. A. & Campbell, K. P. (2002). Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell, 110(5), 639-48. PMID: 12230980.

Girnun, G. D., Domann, F. E., Moore, S. A. & Robbins, M. E. (2002). Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol, 16(12), 2793-801. PMID: 12456800.

Berg, D. J., Zhang, J., Weinstock, J. V., Ismail, H., Earle, K. A., Alila, H., Pamukcu, R., Moore, S. A. & Lynch, R. G. (2002). Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology, 123(5), 1527-42. PMID: 12404228.

Fang, X., Chen, P. & Moore, S. A. (2002). The oxygen radical scavenger pyrrolidine dithiocarbamate enhances interleukin-1beta-induced cyclooxygenase-2 expression in cerebral microvascular smooth muscle cells. Microvascular research, 64(3), 405-13. PMID: 12453435.

Moore, S. A., Saito, F., Chen, J., Michele, D. E., Henry, M., Messing, A., Cohn, R. D., Ross-Barta, S. E., Westra, S., Williamson, R. A., Hoshi, T. & Campbell, K. P. (2002). Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature, 418(6896), 422-5. PMID: 12140559.

Katz, R., Hamilton, J. A., Spector, A. A., Moore, S. A., Moser, H. W., Noetzel, M. J. & Watkins, P. A. (2001). Brain uptake and utilization of fatty acids: recommendations for future research. J Mol Neurosci, 16, 333-335. PMID: 11478387.

Watkins, P. A., Hamilton, J. A., Leaf, A., Spector, A. A., Moore, S. A., Anderson, R. E., Moser, H. W., Noetzel, M. J. & Katz, R. (2001). Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. J Mol Neurosci, 16, 87-92. PMID: 11478388.

Berg, D. J., Lynch, R. & Moore, S. A. (2001). IL-10 is a central regulator of cyclooxygenase expression and prostaglandin production. FASEB J.

Moore, S. A., Saito, F., Henry, M., Messing, A., Cohn, R. D., Williamson, R. & Campbell, K. P. (2001). Selective deletion of brain dystroglycan results in neuronal migration errors. (Vols. 60). pp. 512. J Neuropathol Exp Neurol.

Wickland, M. P., Moore, S. A., Campbell, K. P., Mathews, K., Wall, C., Shilling, C., King, N., King, W., Serrano, C., Kissel, J. T., Fenichel, G. M., Griggs, R. C., Pestronk, A., Stedman, H., Stolle, D. & Mendell, J. R. (2001). Molecular and clinical characterization of individuals with limb-girdle muscular dystrophy. American Academy of Neurology Meeting.

Piccolo, F., Moore, S. A., Mathews, K. & Campbell, K. P. (2001). Limb-girdle muscular dystrophies. In R. Pourmand , Y. Harati (Eds.) Neuromuscular Disorders. pp. 273-291. Lippencott Williams & Wilkins, Philadelphia. Adv Neurol.

Sluka, K. A., Kalra, A. & Moore, S. A. (2001). Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle & nerve, 24(1), 37-46. PMID: 11150964.

Williard, D. E., Harmon, S. D., Preuss, M. A., Kaduce, T. L., Moore, S. A. & Spector, A. A. (2001). Production and release of docosahexaenoic acid by differentiated rat brain astrocytes. In T. Hamazaki , H. Okuyama (Eds.) Proceedings of the 4th Congress of ISSFAL, Fatty Acids and Lipids – New Findings. (Vols. 88). pp. 168-172. World Rev Nutr Diet.

Moore, S. A. (2001). Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci, 16, 195-200. PMID: 11478374.

Hindman, B. J., Moore, S. A., Cutkomp, J., Smith, T., Ross-Barta, S. E., Dexter, F. & Brian, J. E. (2001). Brain expression of inducible cyclooxygenase 2 messenger RNA in rats undergoing cardiopulmonary bypass. Anesthesiology, 95(6), 1380-8. PMID: 11748396.

Afifi, A. K., Follett, K. A., Greenlee, J. D., Scott, W. & Moore, S. A. (2001). Optic neuritis: a novel presentation of Schilder's disease. J Child Neurol, 16(9), 693-6. PMID: 11575614.

Williard, D. E., Harmon, S. D., Kaduce, T. L., Preuss, M., Moore, S. A., Robbins, M. E. & Spector, A. A. (2001). Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J Lipid Res, 42(9), 1368-76. PMID: 11518755.

Cohn, R. D., Durbeej, M., Moore, S. A., Coral-Vazquez, R., Prouty, S. & Campbell, K. P. (2001). Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest, 107(2), R1-7. PMID: 11160141.

Moore, S. A., Saito, F., Henry, M., Messing, A., Cohn, R. D., Williamson, R. & Campbell, K. P. (2001). Abnormal brain development following selective deletion of dystroglycan. Society for Neuroscience.

Grzybicki, D. M., Liu, Y., Moore, S. A., Brown, H. G., Silverman, J. F., D'Amico, F. & Raab, S. S. (2001). Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors. Cancer, 92(10), 2720-6. PMID: 11745208.

Chen, Y., Zhang, J., Moore, S. A., Ballas, Z. K., Portanova, J. P., KRIEG, A. M. & Berg, D. J. (2001). CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. Int Immunol, 13(8), 1013-20. PMID: 11470771.

Berg, D. J., Zhang, J., Lauricella, D. M. & Moore, S. A. (2001). Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J Immunol, 166(4), 2674-80. PMID: 11160331.

Felice, K. J., Moore, S. A. (2001). Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle & nerve, 24(3), 352-6. PMID: 11353419.

Brian, J. E., Faraci, F. M. & Moore, S. A. (2001). COX-2-dependent delayed dilatation of cerebral arterioles in response to bradykinin. Am J Physiol Heart Circ Physiol, 280(5), H2023-9. PMID: 11299202.

Moore, S. A., Ross-Barta, S., Weydert, J. & Yoder, E. (2000). COX-2 expression in cerebral endothelium: a delayed effect of bradykinin. (Vols. 59). pp. 459. J Neuropathol Exp Neurol.

Moore, S. A., Bilunas, M. H. (2000). Amyloid-beta peptide induces cyclooxygenase-2 expression and activity in brain-derived cells. (Vols. 59). pp. 448. J Neuropathol Exp Neurol.

Durbeej, M., Cohn, R. D., Hrstka, R. F., Moore, S. A., Allamand, V., Davidson, B. L., Williamson, R. A. & Campbell, K. P. (2000). Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Molecular cell, 5(1), 141-51. PMID: 10678176.

Barresi, R., Moore, S. A., Stolle, C. A., Mendell, J. R. & Campbell, K. P. (2000). Expression of gamma-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. J Biol Chem, 275(49), 38554-60. PMID: 10993904.

Piccolo, F., Moore, S. A., Ford, G. C. & Campbell, K. P. (2000). Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies. Ann Neurol, 48(6), 902-12. PMID: 11117547.

Felice, K. J., North, W. A., Moore, S. A. & Mathews, K. (2000). FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy. Neurology, 54(10), 1927-31. PMID: 10822431.

Fang, X., Moore, S. A., Nwankwo, J. O., Weintraub, L. N., Oberley, W. L., Snyder, D. G. & Spector, A. A. (2000). Induction of cyclooxygenase-2 by overexpression of the human catalase gene in cerebral microvascular endothelial cells. J Neurochem, 75(2), 614-23. PMID: 10899936.

Crosbie, R. H., Lim, L. E., Moore, S. A., Hirano, M., Hays, A. P., Maybaum, S. W., Collin, H., Dovico, S. A., Stolle, C. A., Fardeau, M., Tomé, F. M. & Campbell, K. P. (2000). Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Hum Mol Genetics, 9(13), 2019-27. PMID: 10942431.

Yoder, E. J., Rich, G., Hilfers, M. A., Albright, J. P., Weydert, J. & Moore, S. A. (1999). Cerebrovascular cyclooxygenase-2 (COX-2) is regulated by pro- and anti-inflammatory agents. (Vols. 58). pp. 542. J Neuropathol Exp Neurol.

Girnun, G. D., Moore, S. A., Oberley, L. W. & Robbins, M. E. (1999). Eicosapentaenoic acid alters Mn-SOD levels in normal but not malignant CNS-derived cells. In K. V. Honn , L. J. Marnett , S. Nigam (Eds.) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, vol 4. (Vols. 469). pp. 647-653. Plenum Publishing Corp., New York, NY, Adv Exp Med Biol.

Moore, S. A., Yoder, E. J., Rich, G., Hilfers, M. & Albright, J. P. (1999). Regulation of cerebrovascular cyclooxygenase-2 by pro- and anti-inflammatory cytokines. In Honn , L. J. Marnett , S. Nigam (Eds.) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, vol 4. pp. 125-130. Plenum Publishing Corp., Adv Exp Med Biol.

Grzybicki, D. M., Moore, S. A. (1999). Implications of prognostic markers in brain tumors. Clin Lab Med, 19, 833-847.

Moore, S. A., Weydert, J., Yoder, E., Faraci, F. M. & Brian Jr, J. E. (1999). Bradykinin induces COX-2 in cerebral endothelium. (Vols. 13). pp. A1072. GASEB j.

Brian Jr, J. E., Moore, S. A. & Faraci, F. M. (1999). COX-2 mediated effects of bradykinin in cerebral arterioles. (Vols. 13). pp. A1072. FASEB J.

Hilfers, M. A., Moore, S. A. (1999). Amyloid-beta peptide induces cyclooxygenase-2 expression and activity in brain-derived cells. Society for Neuroscience Meeting.

Cohn, R. D., Coral, R., Moore, S. A., Hill, J. A., Weiss, R. M., Davisson, R., Straub, V., Bansal, D., Williamson, R. & Campbell, K. P. (1999). Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism in the pathogenesis of ischemic cardiomyopathy and muscular dystrophy. 72nd Scientific Sessions of the American Heart Association.

Girnum, G. D., Domann, F. E., Moore, S. A. & Robbins, M. E. (1999). Nuclear hormone receptors and polyunsaturated fatty acids modulate catalase gene expression. AACR Annual Meeting.

Sluka, K. A., kalra, A. & Moore, S. A. (1999). A new model of chronic muscle pain. Society for Neuroscience Meeting.

Coral-Vazquez, R., Cohn, R. D., Moore, S. A., Hill, J. A., Weiss, R. M., Davisson, R. L., Straub, V., Barresi, R., Bansal, D., Hrstka, R. F., Williamson, R. & Campbell, K. P. (1999). Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell, 98(4), 465-74. PMID: 10481911.

Moore, S. A., Coral, R., Cohn, R. D., Straub, V., Williamson, R. & Campbell, K. P. (1999). Severe muscular dystrophy and cardiomyopathy in mice deficient in delta-sarcoglycan. 75th Annual Meeting of the American Association of Neuropathologists in Portland, OR.

Moore, S. A., Yoder, E. J., Campbell, I. & Murphy, S. (1998). Cerebral endothelial cyclooxygenase-2 (COX-2) is induced by cytokine-activated astrocytes. (Vols. 12). pp. A674. FASEB J.

Garell, P. C., Menezes, A. H., Baumbach, G. L., Moore, S. A., Nelson, G., Mathews, K. & Afifi, A. K. (1998). Presentation, management and follow-up of Schilder's disease. Pediatr Neurosurg, 29(2), 86-91. PMID: 9792962.

Spector, A. A., Moore, S. A. & Yorek, M. A. (1998). Docosahexaenoic acid metabolism and function in the central nervous system: studies with cell culture model systems. In R. A. Riemersma , R. Armstrong & T. W. Kelly , R. Wilson (Eds.) Essential Fatty Acids and Eicosanoids: Invited Papers from the Fourth International Congress.. pp. 16-18. AOCS Press, Champaign IL.

Bohlken, D. P., Alden, B. & Moore, S. A. (1998). Detection of chromosome 4q35 deletion associated with facioscapulohumeral muscular dystrophy (FSHD) by Southern blot analysis. (Vols. 153). pp. 1650. Am J Pathol.

Rich, G., Yoder, E. J. & Moore, S. A. (1998). Regulation of prostaglandin H synthase-2 expression in cerebromicrovascular smooth muscle by serum and epidermal growth factor. J Cell Physiol, 176(3), 495-505. PMID: 9699502.

Grzybicki, D., Moore, S. A., Schelper, R., Glabinski, A. R., Ransohoff, R. M. & Murphy, S. (1998). Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta neuropathologica, 95(1), 98-103. PMID: 9452827.

Moore, S. A., Yoder, E. J., Campbell, I. & Murphy, S. (1998). Cerebrovascular cyclooxygenase-2 (COX-2) is induced by activated astrocytes. Society for Neuroscience Meeting.

Brian, J. E., Moore, S. A. & Faraci, F. M. (1998). Expression and vascular effects of cyclooxygenase-2 in brain. Stroke; a journal of cerebral circulation, 29(12), 2600-6. PMID: 9836773.

Duclos, F., Straub, V., Moore, S. A., Venzke, D. P., Hrstka, R. F., Crosbie, R. H., Durbeej, M., Lebakken, C. S., Ettinger, A. J., van der Meulen, J., Holt, K. H., Lim, L. E., Sanes, J. R., Davidson, B. L., Faulkner, J. A., Williamson, R. & Campbell, K. P. (1998). Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol, 142(6), 1461-71. PMID: 9744877.

Fang, X., Moore, S. A., Stoll, L. L., Rich, G., Kaduce, T. L., Weintraub, N. L. & Spector, A. A. (1998). 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. Am J Physiol, 275(6 Pt 2), H2113-21. PMID: 9843811.

Fang, X., Weintraub, N. L., Moore, S. A., Kaduce, T. L. & Spector, A. A. (1998). 14,15-Epoxyeicosatrienoic acid enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation. 71st Scientific Sessions of the American Heart Association.

Bohlken, D. P., Alden, B. & Moore, S. A. (1998). Detection of chromosome 4q35 deletion associated with facioscapulohumeral muscular dystrophy (FSHD) by Southern blot analysis. Association for Molecular Pathology Annual Meeting.

Hilfers, M. A., Moore, S. A. (1998). Cyclooxygenase-2 expression and activity are blunted in nitric oxide synthase-2 null astrocytes. Society for Neuroscience Meeting.

Xu, J., Wu, Y., He, L., Yang, Y., Moore, S. A. & Hsu, C. Y. (1997). Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem Biophys Res Commun, 235(2), 394-7. PMID: 9199204.

Mathews, K., Moore, S. A., Straub, V., Mills, K. & Campbell, K. P. (1997). Immunohistochemical analysis of myodystrophy mouse muscle. American Association of Neurologists.

Sawin, P. D., Traynelis, V. C., Rich, G., Smith, B. A., Maves, T. J., Follett, K. A. & Moore, S. A. (1997). Chymopapain-induced reduction of proinflammatory phospholipase A2 activity and amelioration of neuropathic behavioral changes in an in vivo model of acute sciatica. J Neurosurg, 86(6), 998-1006. PMID: 9171179.

Hilfers, M. A., Moore, S. A. (1997). Docosahexaenoate enhances the TNF? induction of cyclooxygenase-2 in cerebral endothelium. Society for Neuroscience Meeting.

Moore, S. A., Yoder, E. J., Rich, G. & Albright, J. (1997). Regulation of cerebrovascular cyclooxygenase-2 by pro- and anti-inflammatory cytokines. 5th International Conference on Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation and Related Diseases.

Gard, A. L., Pennica, D., Moore, S. A. & Ford, O. (1997). Cardiotrophin-1 induces an astrocyte phenotype in cultured oligodendrocyte progenitors. Society for Neuroscience Meeting.

Moore, S. A., Yoder, E. J. & Rich, G. (1997). Cerebrovascular cyclooxygenase-2 expression is regulated by pro- and anti-inflammatory cytokines. Society for Neuroscience Meeting.

Girnun, G. D., Moore, S. A., Oberley, L. W. & Robbins, M. E. (1997). Eicosapentaenoic acid alters Mn-SOD levels in normal but not malignant CNS-derived cells. 5th International Conference on Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation and Related Diseases.

Menezes, A. H., Garell, C., Baumbach, G. L., Moore, S. A., Afifi, A. & Mathews, K. (1996). Myelinoclastic diffuse sclerosis (Schilder’s disease) presenting a intracranial masses in childhood. Joint Section on Pediatric Neurological Surgery.

Rich, G., Yoder, E. J., Prokuski, L. & Moore, S. A. (1996). Prostaglandin production in cultured cerebral microvascular smooth muscle is serum dependent. The American journal of physiology, 270(5 Pt 1), C1379-87. PMID: 8967438.

Sawin, P. D., Traynelis, V. C., Rich, G., Smith, B. A., Maves, T. J., Follett, K. A. & Moore, S. A. (1996). Inhibition of phospholipase A2 activity by chymopapain in an in vivo model of acute sciatica.

Rich, G., Yoder, E. J. & Moore, S. A. (1996). Regulation of prostaglandin H synthase-2 expression in cerebral microvascular smooth muscle by serum and EGF. (Vols. 10). pp. A302. FASEB J.

Shafer, R., Moore, S. A., Campbell, I. & Murphy, S. (1996). Activated astrocytes induce nitric oxide synthase-2 expression in cerebrovascular endothelial cells. Society for Neuroscience Meeting.

Moore, S. A., Yoder, E. J. & Rich, G. (1996). Prostaglandin H synthase expression in cultured cerebral endothelium. (Vols. 10). pp. A585. FASEB J.

Grzybicki, D., Loihl, A., Kardos, S., Schelper, R., Moore, S. A., Glabinski, A. R., Ransohoff, R. M. & Murphy, S. (1996). Expression of chemokines and nitric oxide synthase-2 following cerebral trauma. Society for Neuroscience Meeting.

Moore, S. A., Yoder, E. J. & Rich, G. (1996). Prostaglandin H synthase expression in cultured cerebral vascular endothelium and smooth muscle. Frontiers in Bioactive Lipids '96 (XVIth Washington International Spring Symposium).

Moore, S. A., Yoder, E. J. & Rich, G. (1996). Cytokines regulate prostaglandin H sythase-2 in cerebral microvascular endothelium. Society for Neuroscience Meeting.

Spector, A. A., Moore, S. A. (1996). Role of docosahexaenoic acid in the brain. Lipid Forum at the Norwegian Academy for Science and Letters - “Interconversion of polyunsaturated fatty acids, and their functions in membranes.”.

Mills, K. A., Moore, S. A., Tresnak, J. & Mathews, K. (1996). Physical mapping around the myodystrophy locus on mouse chromosome 8. 10th International Mouse Genome Conference.

Slagel, D. D., Goeken, J. A., PLATZ, C. E. & Moore, S. A. (1995). Primary germinoma of the spinal cord: a case report with 28-year follow-up and review of the literature. Acta neuropathologica, 90(6), 657-9. PMID: 8615089.

Moore, S. A., Yoder, L. J. (1995). Prostaglandin H synthase-2 (PGHS-2) is induced in mouse brain following freeze injury. (Vols. 9). pp. A381. FASEB J.

Yoder, E. J., VanRollins, M. & Moore, S. A. (1995). Epoxyeicosatrienoic acid (EET) metabolism by cerebral endothelium. (Vols. 9). pp. A374. FASEB J.

Moore, S. A. (1995). Targeting of omega-3 fatty acids and synthesis of docosahexaenoic acid at the blood-brain barrier. In Proceedings from the Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.. pp. 186-192. American Heart Association Conference Proceedings..

Muhonen, M. G., Piper, J. G., Moore, S. A. & Menezes, A. H. (1995). Cervical epidural hematoma secondary to an extradural vascular malformation in an infant: case report. Neurosurgery, 36(3), 585-7; discussion 587-8. PMID: 7753359.

Rich, G., Prokuski, L. J., Yoder, E. J. & Moore, S. A. (1995). Epidermal growth factor induces prostaglandin H synthase-2 in cerebral microvascular smooth muscle. Society for Neuroscience Meeting.

Rich, G., Prokuski, L. J., Yoder, L. J. & Moore, S. A. (1995). Cultured cerebral microvascular smooth muscle express prostaglandin H synthase-2. (Vols. 9). pp. A374. FASEB J.

Moore, S. A., Hurt, E., Yoder, E., Sprecher, H. & Spector, A. A. (1995). Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. J Lipid Res, 36(11), 2433-43. PMID: 8656081.

Simon, J. S., Baum, J. S., Moore, S. A. & Kasson, B. G. (1995). Arginine vasopressin stimulates protein synthesis but not proliferation of cultured vascular endothelial cells. J Cardiovasc Pharmacol, 25(3), 368-75. PMID: 7769800.

Moore, S. A. (1994). Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain - a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid. In C. Galli , E. Tremoli (Eds.) Fatty Acids and Lipids: Biological Aspects. pp. 128-133. World Rev Nutr Diet.

Fitzsimmons, K. M., Moore, S. A. (1994). Kuf's disease presenting as spinocerebellar degeneration. (Vols. 4). pp. 456. Brain Pathol.

Moore, S. A., Kirk, J. S. & Ethel, E. (1994). Pharmacologic and RT-PCR characterization of muscarinic receptors in mouse cerebral microvascular smooth muscle. (Vols. 8). pp. A29. FASEB J.

Moore, S. A., Hurt, E. F., Yoder, E., Gordon, J. & Spector, A. A. (1994). Peroxisomal fatty acid retroconversion in the synthesis of docosahexaenoic acid. (Vols. 8). pp. A659. FASEB J.

Moore, S. A., Ionasescu, V. (1994). Giant axonal neuropathy: A case study suggesting selective neuronal vulnerability. (Vols. 4). pp. 537. Brain Pathol.

Moore, S. A. (1994). Schwann cell heterogeneity - might it underlie the diversity seen in Schwann cell tumors?. (Vols. 25). pp. 1113. Human Pathol.

Afifi, A. K., Bell, W. E., Menezes, A. H. & Moore, S. A. (1994). Myelinoclastic diffuse sclerosis (Schilder's disease): report of a case and review of the literature. J Child Neurol, 9(4), 398-403. PMID: 7822732.

Murphy, S., Rich, G., Orgren, K. I., Moore, S. A. & Faraci, F. M. (1994). Astrocyte-derived lipoxygenase product evokes endothelium-dependent relaxation of the basilar artery. Journal of neuroscience research, 38(3), 314-8. PMID: 7523688.

Spector, A. A., Gordon, J. A., Moore, S. A. & Kaduce, T. L. (1994). Beta-oxidation of HETEs: a peroxisomal process. In C. Galli , E. Tremoli (Eds.) Fatty Acids and Lipids: Biological Aspects.. pp. 8-15. World Rev Nutr Diet.

Moore, S. A., Ionasescu, V. (1994). Giant axonal neuropathy: A case study suggesting selective neuronal vulnerability. 12th International Congress of Neuropathology.

Moore, S. A., Hurt, E. F., Yoder, E. J., Gordon, J. A. & Spector, A. A. (1994). Docosahexaenoate synthesis requires peroxisomal fatty acid retroconversion. AHA Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.

Rich, G., Murphy, S., Orgren, K. I., Faraci, F. M. & Moore, S. A. (1994). Astrocytes release a factor which stimulates endothelial nitric oxide production. (Vols. 8). pp. A28. FASEB J.

Moore, S. A. (1994). Targeting of omega-3 fatty acids and synthesis of docosahexaenoic acid at the blood-brain barrier. AHA Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.

Moore, S. A., Hurt, E., Sprecher, H. & Spector, A. A. (1993). Docosahexaenoic acid (22:6?-3) synthesis from ?-3, 24-carbon precursors in cerebral endothelium. (Vols. 7). pp. A383. FASEB J.

Ghoneim, S., Waldschmidt, T. J., Yoder, L., Moore, S. A. & Baumbach, G. L. (1993). Effect of cyclical stretching on cultured rat cerebral vascular smooth muscle cells: a flow cytometric, confocal laser scanning, and transmission electron microscopy study. G. W. Bailey , C. L. Rieder (Eds.) pp. 426-427. Proceedings of the 51st Annual Meeting of the Microscopy Society of America.

Moore, S. A. (1993). Cerebral endothelium and astrocytes cooperate in supplying docosahexaenoic acid to neurons. In L. R. Drewes , A. L. Betz (Eds.) Frontiers in Cerebral Vascualr Biology: Transport and Its Regulation. pp. 229-233. Adv Exp Med Biol.

Spector, A. A., Moore, S. A. (1993). Role of the cerebromicrovascular endothelium and astrocytes in supplying docosahexaenoic acid to the brain. In A. Sinclair , R. Gibson (Eds.) Essential Fatty Acids and Eicosanoids. pp. 100-103. American Oil Chemist's Society Press.

Spector, A. A., Gordon, J. A., Moore, S. A. & Kaduce, T. L. (1993). ?-oxidation of HETEs: a peroxisonal process. 1st International Congress of the International Society for the Study of Fatty Acids and Lipids, Lugano, Switzerland.

Spector, A. A., Moore, S. A., North, L. A., North, J. A., Kaduce, T. L. & Buettner, G. (1993). Effects of omega-3 fatty acids in endothelial cells. In C. A. Drevon , I. Baksaas , H. E. Krokan (Eds.) Omega-3 Fatty Acids: Metabolism and Biological Effects. pp. 173-181. Birkhauser Verlag, Basel, Switzerland.

Xu, J., Zhang, P. S., Moore, S. A., Hsu, C. Y. & Hogan, E. L. (1993). Bradykinin-stimulated phosphoinositide turnover and prostacyclin production regulated by phorbol ester and calcium in cerebral endothelial cells. pp. 1389. Society for Neuroscience Meeting.

Moore, S. A. (1993). Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain - a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid. 1st International Congress of the International Society for the Study of Fatty Acids and Lipids, Lugano, Switzerland.

Simon, J. S., Baum, J. S., Moore, S. A., Johnson, A. K. & Kasson, B. G. (1993). Arginine vasopressin (AVP) stimulates protein synthesis but not cell division in mouse cerebral vascular endothelial and smooth muscle cells. (Vols. 7). pp. A750. FASEB J.

Moore, S. A., Sprecher, H. & Spector, A. A. (1993). Docosahexaenoic acid (22:6?-3) synthesis from 24-carbon precursors in cerebral endothelium. 1st International Congress of the Intern. Soc. for the Study of Fatty Acids and Lipids, Lugano, Switzerland.

Moore, S. A., Sprecher, H. & Spector, A. A. (1993). Synthesis of docosahexaenoic acid (22:6?-3) by astrocytes is independent of ?4-desaturase. 1st International Congress of the Internat. Soc. for the Study of Fatty Acids and Lipids, Lugano, Switzerland,.

Moore, S. A., Hurt, E., Sprecher, H. & Spector, A. A. (1993). Docosahexaenoic acid (22:6??3) synthesis in astrocytes does not require ?4-desaturase activity. American Society for Neurochemistry Meeting.

Rogers, J. W., Sato, Y., Moore, S. A., Afifi, A., Bell, W. & Menezes, A. H. (1993). Schilder's disease mimicking brain tumor. American Society of Neuroradiology.

Spector, A. A., Moore, S. A. (1992). Role of the cerebromicrovascular endothelium and astrocytes in supplying docosahexaenoic acid to the brain. Third International Congress on Essential Fatty Acids and Eicosanoids, Adelaide, Australia.

Burgart, L., Robinson, R. A., Haddad, S. & Moore, S. A. (1992). Proliferating cell nuclear antigen (PCNA) expression in astrocytomas: Correlation with oncogenic abnormalities. International Association of Pathologist's Meeting.

Giordano, M. J., Mathur, S. N. & Moore, S. A. (1992). Differential metabolism of hydroxyeicosatetraenoic acid isomers by mouse cerebromicrovascular endothelium. J Neurochem, 58(1), 374-82. PMID: 1727444.

Gordon, D. L., Biller, J., Moore, S. A. & Rodnitzky, R. (1992). Thalamic ependymoma presenting as recurrent subarachnoid hemorrhage. J Stroke Cerebrovasc Dis, 2, 106-109.

Hart, M. N., Fabry, Z., Love-Homan, L., Sadewasser, K. L. & Moore, S. A. (1992). Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells. Am J Pathol, 141, 421-427.

Mueller, D. P., Moore, S. A., Yuh, W. T. & Sato, Y. (1992). The MRI spectrum of medulloblastoma. Clinical Imaging, 16, 250-255. PMID: 1473031.

Wilke, W., Burgart, L., Robinson, R. A., Haddad, S. & Moore, S. A. (1992). H-Ras mutations in astrocytomas: Correlation with other oncogene abnormalities. International Association of Pathologist's Meeting.

Spector, A. A., Moore, S. A., Gordon, E. E., Gordon, J. A. & Kaduce, T. L. (1992). HETEs and endothelial function. In L. Stein , S. Eisenberg , Y. Stein (Eds.) Atherosclerosis IX, Proceedings of the 9th Internatioanl Symposium on Atherosclerosis. pp. 367-370. R&L Creative Communications Ltd, Tel Aviv.

Simon, J. S., Moore, S. A., Johnson, A. K. & Kasson, B. G. (1992). Localization of arginine-vasopressin (AVP) immunoreactivity in vascular compartments and cultured microvascular endothelial and smooth muscle cells. (Vols. 6). pp. A1738. FASEB J.

Haddad, S. F., Moore, S. A., Schelper, R. L. & Goeken, J. A. (1992). Smooth muscle can comprise the sarcomatous component of gliosarcomas. J Neuropathol Exp Neurol, 51(5), 493-8. PMID: 1381414.

Spector, A. A., Kaduce, T. L., Gordon, J. A., Moore, S. A. & VanRollins, M. (1992). Metabolic fate of 12-lipoxygenase products. International Conference on the Biochemistry of Lipids, France.

Xu, J., Qu, Z. X., Moore, S. A., Hsu, C. Y. & Hogan, E. L. (1992). Receptor-linked hydrolysis of phosphoinositides and production of prostacyclin in cerebral endothelial cells. J Neurochem, 58(5), 1930-5. PMID: 1313855.

Murphy, S., Kardos, S., Moore, S. A., Orgren, K. L. & Faraci, F. M. (1992). Astrocyte modulation of cerebral vessel function via prostanoid and non-prostanoid factors. Society for Neuroscience Meeting.

Spector, A. A., Moore, S. A., North, L. A., North, J. A., Kaduce, T. L. & Buettner, G. R. (1992). Effects of omega-3 fatty acids in endothelial cells. Omega-3 Fatty Acids - Metabolism & Biological Effects, Oslo, Norway.

Henrich, D. E., Gantz, B. J., Moore, S. A. & Schubkegel, A. J. (1992). Undifferentiated small-cell neoplasm of the petrous apex - A case report. Arch Otolaryngol Head Neck Surg, 118(7), 767-70. PMID: 1320897.

Haddad, S. F., Moore, S. A., Schelper, R. L. & Goeken, J. A. (1992). Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol, 51(5), 488-92. PMID: 1381413.

Tonner, D., Belding, P., Moore, S. A. & Schlechte, J. A. (1992). Intracranial dissemination of an ACTH secreting pituitary neoplasm--a case report and review of the literature. J Endocrinol Invest, 15(5), 387-91. PMID: 1324266.

Moore, S. A. (1992). The role of cerebral endothelium and astrocytes in supplying docosahexaenoic acid (22:6?-3) to neurons. Cerebral Vascular Biology Conference, Duluth, MN.

Haddad, S. F., Moore, S. A., Menezes, A. H. & VanGilder, J. C. (1992). Ganglioglioma: 13 years of experience. Neurosurgery, 31(2), 171-8. PMID: 1513423.

Spector, A. A., Moore, S. A. (1991). Effects of polyunsaturated fatty acids in endothelial cells. In N. Simionescu , M. Simionescu (Eds.) Endothelial Cell Dysfunction. pp. 507-524. Plenum Publishing Corp, New York NY.

Burgart, L., Robinson, R. A., Haddad, S. & Moore, S. A. (1991). Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared to other protooncogenes. International Association of Pathologists Meeting.

Mueller, D. P., Moore, S. A., Yuh, W. T. & Sato, Y. (1991). The MRI spectrum of medulloblastoma. 29th Annual Meeting of the American Society of Neuroradiology.

Haddad, S. F., Moore, S. A., Goeken, J. & Schelper, R. L. (1991). Smooth muscle cells can comprise the sarcomatous element of gliosarcomas. (Vols. 50). pp. 291. J Neuropathol Exp Neurol.

Yuh, W. T., Turk, J., Mayr, N. A. & Moore, S. A. (1991). Unusual growth and spread of pituitary adenoma: MR and CT findings in four cases. 29th Annual Meeting of the American Society of Neuroradiology.

Moore, S. A., Yoder, E., Murphy, S., Dutton, G. R. & Spector, A. A. (1991). Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J Neurochem, 56(2), 518-24. PMID: 1824862.

Moore, S. A., Yoder, E., Murphy, S., Dutton, G. R. & Spector, A. A. (1991). Astrocytes, not neurons, produce docosahexaenoic acid (22:6?-3) and arachidonic acid (20:4?-6). Meeting on Neurobiology of Essential Fatty Acids, a satellite meeting of the 13th Biennial Meeting of the International Society for Neurochemistry.

Moore, S. A., Giordano, M. J., Kim, H. Y., Salem Jr, N. & Spector, A. A. (1991). Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase-derived. (Vols. 57). pp. S64. J Neurochem.

Moore, S. A., Giordano, M. J., Kim, H. Y., Salem, N. & Spector, A. A. (1991). Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase derived. J Neurochem, 57(3), 922-9. PMID: 1907312.

Moore, S. A., Giordano, M. J., Kim, H. Y., Salem Jr, N. & Spector, A. A. (1991). Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase-derived. 13th Biennial Meeting of the International Society for Neurochemistry.

Burgart, L. J., Robinson, R. A., Haddad, S. F. & Moore, S. A. (1991). Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes. Modern Pathology, 4(2), 183-6. PMID: 1675468.

Yorek, M. A., Stefani, M. R. & Moore, S. A. (1991). Acute and chronic exposure of mouse cerebral microvessel endothelial cells to increased concentrations of glucose and galactose: effect on myo-inositol metabolism, PGE2 synthesis, and Na+/K(+)-ATPase transport activity. Metabolism: clinical and experimental, 40(4), 347-58. PMID: 1849218.

Haddad, S., Robinson, R. A. & Moore, S. A. (1990). DNA flow cytometry is a predictor of survival in astrocytomas. (Vols. 49). pp. 321. J Neuropathol Exp Neurol.

Moore, S. A. (1990). Brain microvessel 12-HETE is lipoxygenase-derived. Annual Meeting of FASEB.

Moore, S. A., Yoder, L., Murphy, S. & Spector, A. A. (1990). Astrocytes, not neurons, produce 22:6?-3 in the brain. American Society for Neurochemistry Meeting.

Loes, D. J., Ryals, T. J., Moore, S. A. & Yuh, W. T. (1990). Recurrent pituitary adenoma presenting as a posterior fossa mass. American Society for Neuroradiology.

Laszewski, M., Moore, S. A. (1990). Occult invasive pituitary adenoma predisposing to fatal bacterial meningitis. Clin Neuropathol, 9, 101-105.

VanRybroek, J. J., Moore, S. A. (1990). Sudden death from bilateral choroid plexus vascular malformation hemorrhage - A case report. Clin Neuropathol, 9, 39-45. PMID: 2407402.

Ou, Z. X., Xu, J., Moore, S. A., Hsu, C. Y. & Hogan, E. L. (1990). Receptor agonists induced-phosphoinositide (PI) turnover in cultured endothelial cells (ECs) of murine brain. (Vols. 4). pp. A1116. FASEB J.

Moore, S. A. (1990). Brain microvessel 12-HETE is lipoxygenase-derived. (Vols. 4). pp. A1098. FASEB J.

Giordano, M. J., Moore, S. A. (1990). Metabolism of hydroxyeicosatetraenoic acids (HETES) by mouse brain endothelium. Society for Neuroscience Meeting.

Giordano, M. J., Moore, S. A. (1990). Prostacyclin synthetase inhibition by metyrapone in cerebromicrovascular endothelium. American Heart Association, 63rd Scientific Sessions.

Fabry, Z., Waldschmidt, T. J., Moore, S. A. & Hart, M. N. (1990). Antigen presentation by brain microvessel smooth muscle and endothelium. J Neuroimmunol, 28(1), 63-71. PMID: 2111334.

Haddad, S. F., Menezes, A. H., Vangilder, J. C. & Moore, S. A. (1990). Ganglioglioma: a 13 year review. Pediatric Section of the American Association of Neurological Surgeons.

Fabry, Z., Waldschmidt, T. J., Van Dyk, L., Moore, S. A. & Hart, M. N. (1990). Activation of CD4+ lymphocytes by syngeneic brain microvascular smooth muscle cells. J Immunol, 145(4), 1099-104. PMID: 1974273.

Sahagun, G., Moore, S. A. & Hart, M. N. (1990). Permeability of neutral vs anionic dextrans in cultured brain microvascular endothelium. Am J Physiol, 259(1 Pt 2), H162-6. PMID: 1695819.

Moore, S. A., Yoder, E. & Spector, A. A. (1990). Role of the blood-brain barrier in the formation of long-chain omega-3 and omega-6 fatty acids from essential fatty acid precursors. J Neurochem, 55(2), 391-402. PMID: 2115069.

Dyken, M., Biller, J., Yuh, W. T., Fincham, R., Moore, S. A. & Justin, E. (1990). Carotid-cavernous sinus thrombosis caused by Aspergillus fumigatus: magnetic resonance imaging with pathologic correlation--a case report. Angiology, 41(8), 652-7. PMID: 2202234.

Moore, S. A., Figard, P., Spector, A. A. & Hart, M. N. (1989). Eicosanoid production by isolated cerebral microvessels and cultured cerebral endothelium. Ann NY Acad Sci, 559, 471-473.

Xu, J., Chao, J., Moore, S. A., Hogan, E. L. & Hsu, C. Y. (1989). Effects of polymorphonuclear cells (PMNs) on the formation of eicosanoids and kinins by a murine endothelial cell (CEC) line. pp. 1026. Society for Neuroscience Abstracts.

Moore, S. A., Yoder, E. & Spector, A. A. (1989). Human microvascular endothelium produce arachidonate (20:4?-6), eicosapentaenoate (20:5?-3), and docosahexaenoate (22:6?-3) from essential fatty acid precursors. (Vols. 3). pp. A705. FASEB J.

Moore, S. A., Figard, P., Spector, A. A. & Hart, M. N. (1989). Eicosanoid production by isolated cerebral microvessels and cultured cerebral endothelium. In B. Al , N. G. Bazan (Eds.) Arachidonic Acid Metabolism in the Nervous System - Physiological and Pathological Significance. pp. 471-473. The New York Academy of Sciences, New York NY.

Moore, S. A., Prokuski, L. j., Flugum, L. A. & Hart, M. N. (1989). Prostaglandin I2 and E2 production by cultured cerebromicrovascular smooth muscle is dependent upon serum. (Vols. 38). pp. 320. J Neuropathol Exp Neurol.

Sandor, M., Fabry, Z., Moore, S. A., Schelper, R., Hart, M. & Lynch, R. (1989). IgG Fc receptor expression on cell lines established from murine brain. (Vols. 3). pp. A1328. FASEB J.

Yerram, N. R., Moore, S. A. & Spector, A. A. (1989). Eicosapentaenoic acid metabolism in brain microvessel endothelium: effect on prostaglandin formation. J Lipid Res, 30(11), 1747-57. PMID: 2559136.

Moore, S. A., Yoder, E. & Spector, A. A. (1989). Human microvascular endothelium produce arachidonate (20:4?-6), eicosapentaenoate (20:5?-3), and docosahexaenoate (22:6?-3) from essential fatty acid precursors. Annual Meeting of FASEB.

Moore, S. A., Figard, P. H., Spector, A. A. & Hart, M. N. (1989). Brain microvessels produce 12-hydroxyeicosatetraenoic acid. J Neurochem, 53(2), 376-82. PMID: 2501450.

Moore, S. A., Prokuski, L. j., Flugum, L. A. & Hart, M. N. (1989). Prostaglandin I2 and E2 production by cultured cerebromicrovascular smooth muscle is dependent upon serum. 65th Annual Meeting of the American Association of Neuropathologists.

Moore, S. A., Yoder, E. & Spector, A. A. (1989). Cerebral endothelia provide essential fatty acids for the brain. Annual Meeting of the American Society for Neurochemistry Meeting.

Sahagun, G., Moore, S. A., Fabry, Z., Schelper, R. L. & Hart, M. N. (1989). Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. Am J Pathol, 134(6), 1227-32. PMID: 2757116.

Moore, S. A., Spector, A. A. & Hart, M. N. (1988). Eicosanoid metabolism in cerebromicrovascular endothelium. Am J Physiol, 254, C37-C44. PMID: 333721.

Schelper, R. L., Moore, S. A. & Hart, M. N. (1988). True reactive microglia lack muscle-pericyte specific ?-actin. (Vols. 47). pp. 362. J Neuropathol Exp Neurol.

Moore, S. A., Spector, A. A. & Gordon, J. A. (1988). Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res, 27, 271-323. PMID: 3076240.

Sahagun, G., Fabry, Z., Schelper, R. L., Moore, S. A. & Hart, M. N. (1988). Characterization and purification of endothelial cells in culture by flow cytometry using a fluorescent-labeled Griffonia simplicifolia agglutinin-I (GSA) lectin. (Vols. 2). pp. A933. FASEB J.

Sahagun, G., Moore, S. A. & Hart, M. N. (1988). Charge and size effects on transport of sulfated and non-sulfated macromolecules across cultured endothelial monolayers. (Vols. 36). Clin Res.

Perlman, S., Jacobsen, G. & Moore, S. A. (1988). Regional localization of virus in the central nervous system of mice persistently infected with murine coronavirus JHM. Virology, 166(2), 328-38. PMID: 2845647.

Moore, S. A., Prokuski, L. J., Figard, P. H., Spector, A. A. & Hart, M. N. (1988). 12-Hydroxyeicosatetraenoic acid (12-HETE) is produced by cerebral microvessels and inhibits prostaglandin production in cerebral endothelium. (Vols. 2). pp. A1522. FASEB J.

Moore, S. A., Prokuski, L. J., Figard, P. H., Spector, A. A. & Hart, M. N. (1988). Murine cerebral microvascular endothelium incorporate and metabolize 12-hydroxyeicosatetraenoic acid. J Cell Physiol, 137(1), 75-85. PMID: 3170659.

Moore, S. A., Flugum, L. & Spector, A. A. (1988). Cerebromicrovascular endothelium produce 12-HETE. 5th International Symposium on the Biology of Vascular Endothelial Cells.

Moore, S. A., Prokuski, L. J., Figard, P. H., Spector, A. A. & Hart, M. N. (1988). 12-Hydroxyeicosatetraenoic acid (12-HETE) is produced by cerebral microvessels and inhibits prostaglandin production in cerebral endothelium. Annual Meeting of FASEB.

Moore, S. A., Spector, A. A. & Hart, M. N. (1987). 12-hydroxyeicosatetraenoic acid is the major metabolite of arachidonic acid in brain microvessels. (Vols. 46). pp. 400. J Neuropathol Exp Neurol.

Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelia produce prostaglandin I2 and E2 in vitro and release them predominantly from their basal surfaces. (Vols. 14). pp. 337. Canadian J Neurol Sci.

Whitters, E., Schelper, R. L., Moore, S. A. & Hart, M. N. (1987). Lectin and anti-alpha-actin staining to monitor purity of endothelium and vascular muscle culture. (Vols. 46). pp. 1230. Fed Proc.

Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelial eicosanoid production in vitro. (Vols. 46). pp. 355. Fed Proc.

Biller, J., Loftus, C. M., Moore, S. A., Schelper, R. L., Danks, K. R. & Cornell, S. H. (1987). Isolated central nervous system angiitis first presenting as spontaneous intracranial hemorrhage. Neurosurgery, 20(2), 310-5. PMID: 3561741.

Lagreze, H. L., Brooks, B. R., Moore, S. A., Spencer, S. E., Kornguth, S. E., Bridges, A. J., Levine, R. L. & Perlman, S. B. (1987). Familial amyotrophy, neuropathy, chorea and dementia with spherocytosis/elliptocytosis: a new syndrome. (Vols. 37 (Suppl)). pp. 139. Neurol.

Schelper, R. L., Moore, S. A. & Whitters, E. (1987). True reactive microglia: non-monocytic, non-pericytic cells of the CNS. (Vols. 46). pp. 1321. Fed Proc.

Vinters, H. V., Reave, S., Costello, P., Girvin, J. P. & Moore, S. A. (1987). Isolation and culture of cells derived from human cerebral microvessels. Cell and tissue research, 249(3), 657-67. PMID: 3664609.

Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelia release prostaglandins in response to thrombin, bradykinin, serotonin and acetylcholine. Annual Meeting of the Society for Neuroscience.

Hart, M. N., VanDyk, L. F., Moore, S. A., Shasby, D. & Cancilla, P. A. (1987). Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. J Neuropathol Exp Neurol, 46(2), 141-53. PMID: 2434625.

Moore, S. A., Spector, A. A. & Hart, M. N. (1987). 12-hydroxyeicosatetraenoic acid is the major metabolite of arachidonic acid in brain microvessels. 63rd Annual Meeting of the American Association of Neuropathologists.

Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelia produce prostaglandin I2 and E2 in vitro and release them predominantly from their basal surfaces. Biology of Cerebral Endothelium Symposium.

Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelial eicosanoid production in vitro. 71st Annual Meeting of the Federation of American Societies for Experimental Biology.

Spencer, S. E., Walker, F. O. & Moore, S. A. (1987). Chorea-amyotrophy with chronic hemolytic anemia: a variant of chorea-amyotrophy with acanthocytosis. Neurology, 37(4), 645-9. PMID: 3561776.

Hart, M. N., Waldschmidt, T. J., Hanley-Hyde, J. M., Moore, S. A., Kemp, J. D. & Schelper, R. L. (1987). Brain microvascular smooth muscle expresses class II antigens. J Immunol, 138(9), 2960-3. PMID: 3471815.

Smoker, W. R., Biller, J., Moore, S. A., Beck, D. W. & Hart, M. N. (1986). Intradural spinal teratoma: report of a case and review of the literture. Am J Neuroradiol, 7(905-910). PMID: 3096113.

Hart, M. N., Moore, S. A., Van Dyk, L. F. & Roberts, R. (1986). Are tight junctions necessary for blood-brain barrier function?.

Barloon, T. J., Moore, S. A. & Mitros, F. A. (1986). A case of stenotic obstruction of the jejunum secondary to slow-release potassium. Am J Gastroenterol, 81(3), 192-4. PMID: 3953535.

Moore, S. A., Schelper, R. L., Hart, M. N., Robinson, R. A. & Whitters, E. (1985). Glomeruloid hyperplasia in glioblastoma: origin from smooth muscle cells. 62nd Annual Meeting of the American Association of Neuropathologists..

Moore, S. A., Schelper, R. L., Hart, M. N., Robinson, R. A. & Whitters, E. (1985). Glomeruloid hyperplasia in glioblastoma: origin from smooth muscle cells. (Vols. 45). pp. 327. J Neuropathol Exp Neurol.

Vinters, H. V., Reave, S., Costello, P., Girvin, J. P. & Moore, S. A. (1985). Isolation and culture of cells derived from human cerebral microvessels. (Vols. 44). pp. 338. J Neuropathol Exp Neurol.

Schelper, R. L., Hart, M. N., Moore, S. A. & Whitters, E. (1985). True reactive microglia produced by injury to central neuronal processes. (Vols. 45). pp. 345. J Neuropathol Exp Neurol.

Moore, S. A., Roberts, R., Van Dyk, L. & Hart, M. N. (1985). Cerebral transendothelial electrical resistance in vitro. 61st Annual Meeting of the American Association of Neuropathologists..

Moore, S. A., Roberts, R., Van Dyk, L. & Hart, M. N. (1985). Cerebral transendothelial electrical resistance in vitro. (Vols. 44). pp. 340. J Neuropath Exp Neurol.

Hart, M. N., Tassell, S. K., Sadewasser, K. L., Schelper, R. L. & Moore, S. A. (1985). Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. The American journal of pathology, 119(3), 448-55. PMID: 4014434.

Hart, M. N., Sadewasser, K. L., Tassell, S. K., Waldschmidt, T. J., Schelper, R. L. & Moore, S. A. (1985). Autoimmune vasculitis, a model. (Vols. 44). pp. 957. Fed Proc.

Moore, S. A., Bohlen, H. G., Miller, B. G. & Evan, A. P. (1985). Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats. Blood Vessels, 22, 265-277.

Robinson, R. A., Moore, S. A. & Hart, M. N. (1984). Growth control of cerebral microvessel derived smooth muscle cells. (Vols. 8A). pp. 255. J Cellular Biochem Suppl.

Beck, D. W., Vinters, H. V., Moore, S. A., Hart, M. N., Henn, F. A. & Cancilla, P. A. (1984). Demonstration of adenosine receptors on mouse cerebral smooth muscle membranes. Stroke, 15(725-727). PMID: 6087502.

Moore, S. A., Strauch, A. R., Yoder, E. J., Rubenstein, P. & Hart, M. N. (1984). Cerebral microvascular smooth muscle in tissue culture. In vitro, 20(6), 512-20. PMID: 6235174.

Beck, D. W., Vinters, H. V., Hart, M. N., Henn, F. A., Moore, S. A. & Cancilla, P. A. (1983). Adenosine and cerebral smooth muscle: uptake and binding. (Vols. 42). pp. 484. Fed Proc.

Moore, S. A., Yoder, E., Strauch, A., Rubenstein, P. & Hart, M. N. (1983). Isolation and characterization of mouse cerebral vascular smooth muscle in tissue culture. (Vols. 14). pp. 131. Stroke.

Moore, S. A., Miller, B., Bohlen, H. & Evan, A. (1983). Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats. (Vols. 42). pp. 485. Fed Proc.

Moore, S. A., Miller, B., Bohlen, H. & Evan, A. (1983). Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats. 67th Annual Meeting of the Federation of American Societies for Experimental Biology.

Moore, S. A., Yoder, E., Strauch, A., Rubenstein, P. & Hart, M. N. (1983). Isolation and characterization of mouse cerebral vascular smooth muscle in tissue culture. Eighth International Joint Conference on Stroke and Cerebral Circulation.

Beck, D. W., Vinters, H. V., Moore, S. A., Hart, M. N. & Cancilla, P. A. (1983). Uptake of adenosine by cultured cerebral vascular smooth muscle cells. Journal of neurochemistry, 41(4), 939-41. PMID: 6619860.

Westfall, S. G., Felten, D. L., Mandelbaum, J. A., Moore, S. A. & Peterson, R. G. (1983). Degenerative neuropathy in insulin-treated diabetic rats. Journal of the neurological sciences, 61(1), 93-107. PMID: 6355399.

Moore, S. A., Miller, B., Bohlen, H. & Evan, A. (1983). Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats. 67th Annual Meeting of the Federation of American Societies for Experimental Biology.

Rhodes, G., Holland, M. L., Wiesler, D., Novotny, M., Moore, S. A., Peterson, R. G. & Felten, D. L. (1982). Structural relationships between the endogenous volatile urinary metabolites of experimentally diabetic rats and certain neurotoxins (l). Experientia, 38(1), 75-7. PMID: 7056362.

Rhodes, G., Holland, M. L., Wiesler, D., Novotný, M., Moore, S. A., Peterson, R. G. & Felten, D. L. (1982). Excretion of urinary volatile metabolites in response to alloxan induced diabetes of short duration in rats. Journal of chromatography, 228, 33-42. PMID: 7076757.

Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1982). Ultrastructural axonal pathology in experimentally diabetic and aging control rats. Brain research bulletin, 8(3), 317-23. PMID: 7093738.

Baughman, S., Felten, S. Y., Lee, W., Moore, S. A., O'Connor, B. L. & Peterson, R. G. (1981). The effect of diabetes on leucine and fucose incorporation into PNS myelin proteins. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme, 13(6), 331-5. PMID: 7262834.

Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1981). Glycogen accumulation in tibial nerves of experimentally diabetic and aging control rats. J Neurol Sci, 52, 289-303. PMID: 7310436.

Cartwright, T. R., Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Peripheral neuropathy in diabetic (db/db) mice. (Vols. 28). pp. 797A. Clin Res.

Smith, S. L., Novotny, M., Moore, S. A. & Felton, D. L. (1980). Studies of hyperlipidemia in drug-induced diabetic rats by high-performance liquid chromatography. J Chrom Biomed Appl, 221, 19-26.

Felten, S. Y., Baughman, S., Lee, W., Moore, S. A. & Peterson, R. G. (1980). The effect of diabetes on glycoprotein incorporation into PNS myelin. (Vols. 11). pp. 215. Trans Amer Soc Neurochem.

Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Ultrastructural changes in tibial nerves of two month streptozotocin and alloxan diabetic rats. (Vols. 39). pp. 377. J Neruopathol Exp Neurol.

Moore, S. A., Cartwright, T. R., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Motor and sensory conduction velocity study in the genetically diabetic (db/db) mouse. Midwest Student Medical Research Forum.

Moore, S. A., Cartwright, T. R., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Motor and sensory conduction velocity study in the genetically diabetic (db/db) mouse. (Vols. 28). pp. 801A. Clin Res.

Moore, S. A., Peterson, R. G., Felten, D. L., Cartwright, T. R. & O'Connor, B. L. (1980). Reduced sensory and motor conduction velocity in 25-week-old diabetic [C57BL/Ks (db/db)] mice. Experimental neurology, 70(3), 548-55. PMID: 7439292.

Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1980). A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. Journal of the neurological sciences, 48(1), 133-52. PMID: 6448276.

Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Ultrastructural changes in tibial nerves of two month streptozotocin and alloxan diabetic rats. Am. Assoc. of Neuropathologists Meeting.

Moore, S. A., O'Connor, B. L. & Peterson, R. G. (1979). Experimental diabetic neuropathy - (Dealing with preliminary electron microscopic findings). (Vols. 193). pp. 627. Anat Rec.

Moore, S. A., O'Connor, B. L. & Peterson, R. G. (1979). Experimental diabetic neuropathy - (Dealing with preliminary electron microscopic findings). American Association of Anatomists Meeting.

Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1979). Early segmental demyelination in experimental diabetic neuropathy. (Vols. 5). pp. 515. Neuroscience Abstracts.

Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1979). Experimental diabetic neuropathy - (Dealing with preliminary conduction velocity findings). (Vols. 28). pp. 415. Diabetes.

Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1979). Early segmental demyelination in experimental diabetic neuropathy. Society for Neuroscience Meetings.